A$652,248 (about $430,000) keeps a promising immune-system collaboration going in Australia

The Australian Research Council has awarded Monash University A$652,248 (about $430,000) over three years to continue its long-running collaboration with biotech company Immutep on LAG-3 — one of the immune system's key control switches, and a promising target for new cancer and autoimmune treatments. The partnership has already produced a world first: the crystal structure of LAG-3 bound to its main partner molecule, published in Science Immunology, which gave drug designers their first detailed map of how the switch works. The new Linkage Projects grant keeps the team, and the map-making, going.

SDG 9 · Industry, innovation and infrastructure — Mechanism: funding & finance